Bioavailability & Bioequivalence Summit 2020

LexisConferences invites all the participants across the globe to attend the International conference on Bioavailability & Bioequivalence during October 30-31, 2020 at Chicago, USA. 

Bioavailability 2020 provides the best platform for the researchers to the researchers all over globe to introduce themselves to the innovative world with their unique ideas and research. It is basically aimed at the Clinical Practitioners, medical/ health practitioners, students, professionals, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors and Suppliers of Drug Delivery Technologies, Business Entrepreneurs, Health professionals & Pharmacist, professional bodies and institutions.

Bioavailability 2020 is planned with the keynote sessions, session lectures, poster presentations, presentations from the young researchers, panel discussions, and the B2B meetings with world-renowned speakers from the field of clinical and pharmaceutical sciences.

The scope of the Bioavailability 2020 on all areas of Pharmacokinetics, Pharmacodynamics, Bioavailability, Drug delivery, Drug discovery, Drug metabolism, Sample preparation for analysis, etc.

Market Analysis

• The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021.
• The Sales of generic drugs in Canada rose from $3.0 billion in 2006 to $5.5 billion in 2016 at a rate of growth similar to the other industrialized countries.
• Generic drugs considered to be 74% of the volume of drugs in the Canadian pharmaceutical market in 2016 which is the third highest among the OECD countries after the United States and Germany.
• Canadians spent $165 per capita on generic drugs in 2016 which is the second highest among the OECD countries after the United States.